Important Safety Information for Patients Receiving Ultomiris® Show this card to any doctor involved in your care.

This guide is for the parents/legal guardians of young children and Infants treated with ravulizumab. This parent information brochure is a supportive document specifically developed in order to describe the symptoms and steps for early detection and management of meningococcal infections in infants and young children. The primary source of information for patients is within the patient guides.

Important risk minimisation information for patients with Paroxysmal Nocturnal Haemoglobinuria (PNH), Atypical Haemolytic Uremic Syndrome (aHUS), Generalised Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD).